Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled study of fremanezumab in Chinese adults with migraine has completed, including an open-label period. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Ajovy (fremanezumab)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2025-01-31